Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Large Volume Increase - Should You Buy?

Key Points

• Bayer Aktiengesellschaft's trading volume increased by 92% on Monday, with 1,506,045 shares traded, even as the stock price dipped to $8.38 from a previous close of $8.56.
• Analyst ratings for the stock vary, with some upgrades to strong-buy and downgrades to hold, resulting in a current consensus rating of "Buy."
• Despite a negative net margin of 7.26%, Bayer reported better-than-expected earnings of $0.65 per share and revenue of $15.27 billion in its last quarterly results.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) shares saw an uptick in trading volume on Monday . 1,506,045 shares traded hands during trading, an increase of 92% from the previous session's volume of 785,728 shares.The stock last traded at $8.38 and had previously closed at $8.56.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on BAYRY shares. Wall Street Zen downgraded Bayer Aktiengesellschaft from a "buy" rating to a "hold" rating in a research report on Saturday. Kepler Capital Markets upgraded Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report on Wednesday, June 11th. Hsbc Global Res upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. Finally, The Goldman Sachs Group upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Bayer Aktiengesellschaft presently has a consensus rating of "Buy".

Bayer Aktiengesellschaft Stock Performance

The company has a market cap of $32.81 billion, a PE ratio of -9.08 and a beta of 0.86. The company has a quick ratio of 0.79, a current ratio of 1.25 and a debt-to-equity ratio of 1.07. The company has a 50-day moving average of $7.64 and a 200-day moving average of $6.57.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.02. The company had revenue of $15.27 billion for the quarter, compared to analysts' expectations of $13.39 billion. Bayer Aktiengesellschaft had a positive return on equity of 13.94% and a negative net margin of 7.26%. As a group, analysts anticipate that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.